Milton G. Mutchnick

1.7k total citations
78 papers, 1.4k citations indexed

About

Milton G. Mutchnick is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Milton G. Mutchnick has authored 78 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 28 papers in Hepatology and 13 papers in Immunology. Recurrent topics in Milton G. Mutchnick's work include Hepatitis C virus research (22 papers), Liver Disease Diagnosis and Treatment (18 papers) and Hepatitis B Virus Studies (12 papers). Milton G. Mutchnick is often cited by papers focused on Hepatitis C virus research (22 papers), Liver Disease Diagnosis and Treatment (18 papers) and Hepatitis B Virus Studies (12 papers). Milton G. Mutchnick collaborates with scholars based in United States, Italy and Germany. Milton G. Mutchnick's co-authors include Harold O. Conn, Paul H. Naylor, Murray N. Ehrinpreis, Michael M. Phillips, Allan L. Goldstein, Emanuel Lerner, Edward H. Storer, Gale R. Ramsby, Joseph L. Kinzie and G. D. Cummings and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Hepatology.

In The Last Decade

Milton G. Mutchnick

74 papers receiving 1.3k citations

Peers

Countries citing papers authored by Milton G. Mutchnick

Since Specialization

Citations

This map shows the geographic impact of Milton G. Mutchnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milton G. Mutchnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milton G. Mutchnick more than expected).

Fields of papers citing papers by Milton G. Mutchnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milton G. Mutchnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milton G. Mutchnick. The network helps show where Milton G. Mutchnick may publish in the future.

Co-authorship network of co-authors of Milton G. Mutchnick

This figure shows the co-authorship network connecting the top 25 collaborators of Milton G. Mutchnick. A scholar is included among the top collaborators of Milton G. Mutchnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milton G. Mutchnick. Milton G. Mutchnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bleeding Mass in Remnant Stomach, Unveiling Lynch Syndrome 18 Years After Bariatric Roux-En-Y Gastric Bypass Surgery 2024 ·ACG Case Reports Journal ·(unknown), (unknown), (unknown), (unknown), John Webber, Milton G. Mutchnick	1
2	Manifestation and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease in a Predominately African American Population at a Multi-Specialty Healthcare Organization 2024 ·Healthcare ·(unknown), (unknown), (unknown), (unknown), Paul H. Naylor, Milton G. Mutchnick	0
3	Impact of DAA Treatment for HCV on Hepatocellular Carcinoma in a Predominately African American Population 2024 ·Journal of Gastrointestinal Cancer ·Mohamad I. Itani, (unknown), (unknown), (unknown), (unknown), (unknown), Paul H. Naylor, Eliza W. Beal, Milton G. Mutchnick	2
4	Racial Disparity in HCV Demographics and Treatment Between Interferon Era (2002–2003) and Direct Acting Anti-viral Era (2019) 2023 ·Cureus ·Paul H. Naylor, (unknown), (unknown), Murray N. Ehrinpreis, Milton G. Mutchnick	1
5	Racial Diversity in Hepatocellular Carcinoma in a Predominately African-American Population at an Urban Medical Center 2019 ·Journal of Gastrointestinal Cancer ·(unknown), (unknown), (unknown), (unknown), Paul H. Naylor, Philip Philip, Murray N. Ehrinpreis, Milton G. Mutchnick	2
6	Acute Retroviral Syndrome Presenting as Acute Hepatitis 2018 ·Cureus ·(unknown), (unknown), (unknown), (unknown), Milton G. Mutchnick	2
7	Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach 2017 ·Journal of Viral Hepatitis ·Paul H. Naylor, Milton G. Mutchnick	16
8	Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis C 2016 ·Journal of Clinical and Translational Hepatology ·(unknown), Paul H. Naylor, Suhag Patel, (unknown), (unknown), Fadi Antaki, Milton G. Mutchnick, Murray N. Ehrinpreis	2
9	Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans 2015 ·Journal of Clinical and Translational Hepatology ·Naveen A. Reddy, Paul H. Naylor, (unknown), (unknown), (unknown), (unknown), Murray N. Ehrinpreis, Milton G. Mutchnick	5
10	Interferon (IFN) Based Treatment of African Americans with Chronic Hepatitis C (CHC) in an Urban Clinic: Improving Response with Advances in Therapy 2015 ·Journal of Gastroenterology and Hepatology Research ·Paul H. Naylor, (unknown), (unknown), (unknown), Murray N. Ehrinpreis, (unknown), Milton G. Mutchnick	1
11	Potential Role of Lycopene in the Treatment of Hepatitis C and Prevention of Hepatocellular Carcinoma 2008 ·Nutrition and Cancer ·(unknown), Milton G. Mutchnick, (unknown), Özgür Harmancı, Yusuf Bayraktar, (unknown), Kazım Şahin, Ömer Küçük	16
12	Percutaneous Liver Biopsy Is Safe in Chronic Hepatitis C Patients With End-Stage Renal Disease 2007 ·Clinical Gastroenterology and Hepatology ·Swati Pawa, Murray N. Ehrinpreis, Milton G. Mutchnick, James Janisse, Ravi Dhar, (unknown)	30
13	An Unusual Case of Amoxicillin/Clavulanic Acid-Related Hepatotoxicity 1998 ·The American Journal of Gastroenterology ·(unknown), Milton G. Mutchnick, (unknown), Murray N. Ehrinpreis	18
14	Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C. 1996 ·Gut ·Guido Rasi, (unknown), Milton G. Mutchnick, Filomena Colella, P Sinibaldi Vallebona, Pasquale Pierimarchi, (unknown), Enrico Garaci	46
15	Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial 1991 ·Hepatology ·Milton G. Mutchnick	4
16	Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial 1991 ·Hepatology ·Milton G. Mutchnick, Henry D. Appelman, Hau-Tim Chung, Emma Aragona, (unknown), G. D. Cummings, Jeanne G. Waggoner, Jay H. Hoofnagle, David A. Shafritz	114
17	Thymosin α1 and thymosin β4 modulate human colonic lamina propria lymphocyte function 1990 ·Immunopharmacology ·Yoram Elitsur, Milton G. Mutchnick, Wael Sakr, Gordon D. Luk	4
18	Localization of immunoreactive thymosin α₁ in astrocytes of normal human brain 1989 ·Annals of Neurology ·(unknown), (unknown), Marinos C. Dalakas, Milton G. Mutchnick	24
19	Duodenal Ulcer, Hepatic Abscesses, and Fatal Hemobilia with Behcet's Syndrome: A Case Report 1982 ·Deep Blue (University of Michigan) ·Armin E. Good, Milton G. Mutchnick, Lee Weatherbee	1
20	Influence of SRBC/lymphocyte ratio on T-cell rosettes in alcoholic liver disease and inflammatory bowel disease. 1977 ·PubMed Central ·Milton G. Mutchnick, Douglas White, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact